209 related articles for article (PubMed ID: 28209438)
1. Excessive daytime sleepiness in a patient with coexisting myotonic dystrophy type 1, myasthenia gravis and Graves' disease.
Kapica-Topczewska K; Pogorzelski R; Tarasiuk J; Drozdowski W; Lewczuk P; Kułakowska A
Neurol Neurochir Pol; 2017; 51(2):190-193. PubMed ID: 28209438
[TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis in conjunction with Graves' disease: a diagnostic challenge.
Tanwani LK; Lohano V; Ewart R; Broadstone VL; Mokshagundam SP
Endocr Pract; 2001; 7(4):275-8. PubMed ID: 11497480
[TBL] [Abstract][Full Text] [Related]
3. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
4. Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.
Sehgal S; Rebello R; Wolmarans L; Elston M
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28882932
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma.
Feyma T; Carter GT; Weiss MD
Muscle Nerve; 2008 Jul; 38(1):916-20. PubMed ID: 18563724
[TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophy in a female with myasthenia gravis.
de los Angeles Avaria M; Kleinsteuber K; Novoa F; Faundez P; Carvallo P
Pediatr Neurol; 2007 Jun; 36(6):421-3. PubMed ID: 17560508
[TBL] [Abstract][Full Text] [Related]
7. [Myotonic dystrophy Curschmann-Steinert].
Papageorgiou E; Bock SW; Schiefer U
Klin Monbl Augenheilkd; 2007 Jan; 224(1):70-5. PubMed ID: 17260325
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis and thymoma coexisting with myotonic dystrophy type 1.
Ekmekci O; Karasoy H; Bademkiran F; Akkus DE; Yuceyar N
Neuromuscul Disord; 2014 Jan; 24(1):40-2. PubMed ID: 24291332
[TBL] [Abstract][Full Text] [Related]
9. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
10. Muscle weakness in a girl with autoimmune hepatitis and Graves' disease.
Sarkhy A; Persad R; Tarnopolsky M
Eur J Pediatr; 2009 Feb; 168(2):241-3. PubMed ID: 18604559
[TBL] [Abstract][Full Text] [Related]
11. The coexistence of myasthenia gravis and myotonic dystrophy in one family.
Maytal J; Spiro AJ; Sinnar S; Moshe SL
Neuropediatrics; 1987 Feb; 18(1):8-10. PubMed ID: 3561710
[TBL] [Abstract][Full Text] [Related]
12. New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia gravis.
Bou Ali H; Salort-Campana E; Grapperon AM; Gallard J; Franques J; Sevy A; Delmont E; Verschueren A; Pouget J; Attarian S
Muscle Nerve; 2017 Apr; 55(4):532-538. PubMed ID: 27511866
[TBL] [Abstract][Full Text] [Related]
13. Graves' disease and celiac disease in a patient with myotonic dystrophy type 2.
Damen MJ; van der Meer A; Voermans NC; Tieleman AA
Neuromuscul Disord; 2018 Oct; 28(10):878-880. PubMed ID: 30197184
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1.
Zhong H; Zeng L; Yu X; Ke Q; Dong J; Chen Y; Luo L; Chang X; Guo J; Wang Y; Xiong H; Liu R; Liu C; Wu J; Lin J; Xi J; Zhu W; Tan S; Liu F; Lu J; Zhao C; Luo S
Orphanet J Rare Dis; 2024 Mar; 19(1):103. PubMed ID: 38454488
[TBL] [Abstract][Full Text] [Related]
15. A Myotonic Dystrophy Type I patient with Predominant Proximal Muscle Weakness without Action Myotonia- A Case Report and Review of Pathology.
Wu CI; Chien YY; Lee KY
Acta Neurol Taiwan; 2021 Sep; 30(3)():113-118. PubMed ID: 34841507
[TBL] [Abstract][Full Text] [Related]
16. Sleep disorders in childhood-onset myotonic dystrophy type 1.
Quera Salva MA; Blumen M; Jacquette A; Durand MC; Andre S; De Villiers M; Eymard B; Lofaso F; Heron D
Neuromuscul Disord; 2006 Oct; 16(9-10):564-70. PubMed ID: 16934465
[TBL] [Abstract][Full Text] [Related]
17. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy.
Moyer M; Berger DS; Ladd AN; Van Lunteren E
Muscle Nerve; 2011 Jun; 43(6):818-27. PubMed ID: 21404300
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diagnostic tests in myasthenia gravis.
Nicholson GA; McLeod JG; Griffiths LR
Clin Exp Neurol; 1983; 19():45-9. PubMed ID: 6568927
[TBL] [Abstract][Full Text] [Related]
20. [A 63-year-old woman with muscle weakness, myotonia, and parkinsonism].
Okuma Y; Tanaka S; Nomura Y; Mori H; Yan H; Shirai T; Kondo T; Segawa M; Mizuno Y
No To Shinkei; 1996 Mar; 48(3):287-97. PubMed ID: 8868342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
